Suven Pharmaceuticals Ltd.

NSE: SUVENPHAR | BSE: 543064 | ISIN: INE03QK01018 | Industry: Pharmaceuticals
| Expensive Performer
1151.0000 40.80 (3.68%)
NSE Mar 28, 2025 15:31 PM
Volume: 316.8K
 

1151.00
3.68%
ICICI Securities Limited
Suven’s rapid ascendance in the CDMO space has been remarkable. It has journeyed from being a small molecule-focused CDMO to achieving eminence as one of the few CDMOs in India that offers contract manufacturing of oligonucleotides and ADCs.
Number of FII/FPI investors increased from 181 to 201 in Dec 2024 qtr.
More from Suven Pharmaceuticals Ltd.
Recommended